Indegene and Microsoft partner to accelerate generative AI adoption in life sciences companies.

Indegene and Microsoft have formed a strategic partnership to help life sciences companies accelerate the adoption of generative AI (GenAI) services. The collaboration aims to co-innovate GenAI services and workflows across commercial, medical, regulatory, and clinical functions, focusing on key use cases like content super app, future-ready medical content value chain, and data management and analytics for clinical trials. This partnership will help global life sciences companies leverage AI for faster innovation at scale.